Getting Ready for the OCT Pathway in DESP
Prepare for the integration of the OCT pathway into the English National Diabetic Eye Screening Programme (DESP) and join our webinar on September 4 at 6 pm (UK time) / 7 pm (CEST).
This 90-minute event, made possible by the Canon Medical Academy, will cover the benefits, challenges, and essential training for accurate OCT image grading.
Designed by eye care professionals for eye care professionals, this event is crucial for mastering advancements in diabetic retinopathy management. The inclusion of the OCT pathway in DESP represents a significant leap in diabetic eye care, offering more efficient and accurate screening while reducing the pressure on hospital eye services.
This 90-minute event, made possible by the Canon Medical Academy, will cover the benefits, challenges, and essential training for accurate OCT image grading.
Designed by eye care professionals for eye care professionals, this event is crucial for mastering advancements in diabetic retinopathy management. The inclusion of the OCT pathway in DESP represents a significant leap in diabetic eye care, offering more efficient and accurate screening while reducing the pressure on hospital eye services.
Live Webinar | Getting Ready for the OCT Pathway in DESP
Sign up for the webinar and join Mr. Michael Horler, Mrs. Samantha Mann, and Prof. Tunde Peto as they discuss the inclusion of the OCT pathway in DESP and its benefits and challenges.
Program
Certificate*
All delegates will receive a certificate of attendance.
Program
- Introduction – Mr. Michael Horler
- The New OCT Pathway: Why Was Adding This Pathway Necessary? | Mrs. Samantha Mann
- Cases 1-2: Representative Cases | Mrs. Samantha Mann and Prof. Tunde Peto
- The South London Experience | Mrs. Samantha Mann
- Case 3: From South London | Mrs. Samantha Mann
- Analysing OCT Images and Getting Ready for the DESP Pathway Change | Prof. Tunde Peto
- Cases 4-5: The One Where the Pathway Will Help and the One Where It Will Not! | Prof. Tunde Peto
- Live Q&A moderated by Mr. Michael Horler
- Discover how OCT will change diabetic eye screening
- Get practical tips and learn how to interpret OCT images
- Get more insights into what OCT is
- Participate in the live Q&A to find answers to your questions
Certificate*
All delegates will receive a certificate of attendance.
* Note: The full name entered by joining the live webinar will be used to generate your name on the attendance certificate.
Speakers and Presentations
Moderator:
Mr. Michael Horler, BSc (Hons) MRes FCOptom
Consultant Optometrist
Sussex Eye Hospital, University Hospitals Sussex
Brighton, United Kingdom
Sussex Eye Hospital, University Hospitals Sussex
Brighton, United Kingdom
Discover More About the Moderator
Speaker:
Mrs. Samantha Mann, MD MRCOph FRCOph
Consultant Ophthalmologist and SELDESP Lead
Guy’s & St Thomas’ Hospital Foundation Trust
London, United Kingdom
Presentation: The OCT Pathway: The South London Experience
Optical Coherence Tomography (OCT) scanning will soon be integrated into the English National Diabetic Eye Screening Surveillance Pathway. This advancement will enable patients with mild maculopathy to remain within a surveillance pathway managed by retinal screening rather than being immediately referred to the Hospital Eye Service. Approximately 90% of these patients require only observation, not treatment.
These patients will be monitored every six months with an OCT retinal scan, graded by Diabetes Eye Screening Programme (DESP) practitioners.
This approach will help alleviate the strain on hospital eye services, allowing them to allocate more capacity to patients needing anti-VEGF injections or laser treatments.
Guy’s & St Thomas’ Hospital Foundation Trust
London, United Kingdom
Presentation: The OCT Pathway: The South London Experience
Optical Coherence Tomography (OCT) scanning will soon be integrated into the English National Diabetic Eye Screening Surveillance Pathway. This advancement will enable patients with mild maculopathy to remain within a surveillance pathway managed by retinal screening rather than being immediately referred to the Hospital Eye Service. Approximately 90% of these patients require only observation, not treatment.
These patients will be monitored every six months with an OCT retinal scan, graded by Diabetes Eye Screening Programme (DESP) practitioners.
This approach will help alleviate the strain on hospital eye services, allowing them to allocate more capacity to patients needing anti-VEGF injections or laser treatments.
Discover More About the Speaker
Speaker:
Prof. Tunde Peto, MD, PhD
Professor of Clinical Ophthalmology and Consultant Ophthalmologist
Queen’s University Belfast, Belfast Health and Social Care Trust
Belfast, Ireland
Presentation: Analysing OCT Images and Getting Ready for the DESP Pathway Change
Adding Optical Coherence Tomography (OCT) to the Diabetic Eye Screening Pathway is an exciting development that will likely reduce the burden on patients referred to eye clinics without requiring treatment.
The key challenge is to ensure that all graders receive proper training in grading OCT images and making accurate referrals.
In this presentation, we will explore the thought process behind OCT image grading as we prepare for the implementation of the new pathway.
Queen’s University Belfast, Belfast Health and Social Care Trust
Belfast, Ireland
Presentation: Analysing OCT Images and Getting Ready for the DESP Pathway Change
Adding Optical Coherence Tomography (OCT) to the Diabetic Eye Screening Pathway is an exciting development that will likely reduce the burden on patients referred to eye clinics without requiring treatment.
The key challenge is to ensure that all graders receive proper training in grading OCT images and making accurate referrals.
In this presentation, we will explore the thought process behind OCT image grading as we prepare for the implementation of the new pathway.
Discover More About the Moderator and Speakers
Mr. Michael Horler, BSc (Hons) MRes FCOptom Michael Horler is a consultant optometrist at Sussex Eye Hospital in Brighton. He specializes in medical retinopathy and is a visiting lecturer for the postgraduate optometry course at the University of Hertfordshire.
Previously, Mr. Horler served as the medical retina lead at Moorfields Eye Hospital and taught undergraduate and postgraduate students at the University of Auckland.
He has delivered numerous invited lectures and workshops and co-authored a comprehensive suite of OCT training programs for optometrists.
In 2021, Mr. Horler was awarded a fellowship from the College of Optometrists in recognition of his contributions to the profession of optometry.
Mrs. Samantha Mann, MD MRCOph FRCOph Samantha Mann has been a consultant ophthalmologist at St Thomas’ Hospital for 15 years. With a particular interest in Diabetic Eye Screening, she serves as the clinical lead for the South East London Programme, overseeing the care of over 120,000 patients living with diabetes.
The Programme caters to a highly diverse and often underserved population that regularly encounters advanced levels of pathology.
Dedicated to enhancing service quality, Mrs. Samantha Mann contributed to the development of the London OCT scanning protocol for Diabetic Eye Screening Surveillance Pathways. She created the impactful video "Danny’s Story," highlighting the consequences of missing screening appointments through the experience of a young man blinded by diabetes.
Her latest project features a video documenting the experiences of three individuals with diabetes undergoing retinal laser treatment.
Mrs. Samantha Mann also serves as the current president of the British Association of Retinal Screeners.
Prof. Tunde Peto, MD, PhD Tunde Peto is a professor of clinical ophthalmology at Queen’s University Belfast and the clinical lead for Diabetic Eye Screening in Northern Ireland.
She also serves as a consultant ophthalmologist and clinical lead for Diabetic Eye at the Belfast Trust. With extensive experience in diabetic eye screening in the UK since 2002, Prof. Peto is highly regarded for her expertise in teaching and training for diabetic eye disease.
Her international contributions to the field have been recognized with the prestigious Eva Kohner Award.
Other webinars that may interest you
Disclaimers
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
